Friday 21 February, 2020
Benchmark Hlgs PLC
Director/PDMR Shareholding
RNS Number : 7566D
Benchmark Holdings PLC
21 February 2020
21 February 2020
BENCHMARK HOLDINGS PLC
("Benchmark" or the "Company" or the "Group")
PDMR Shareholding
The Company announces, further to the announcement made on 30 January 2020, that the following persons discharging managerial responsibilities (PDMRs) for the purposes of Article 19 of the Market Abuse Regulation (EU 596/2014) participated in the Placing and/or Open Offer (the "Fundraising").
Name
|
Number of existing Ordinary Shares
|
Number of Placing Shares subscribed for
|
Number of Open Offer shares subscribed for and awarded
|
Number of Ordinary Shares now held
|
Percentage of Enlarged Share Capital now held
|
Peter George
|
1,000,000
|
1,250,000
|
68,219
|
2,318,219
|
0.35%
|
Septima Maguire
|
-
|
250,000
|
-
|
250,000
|
0.04%
|
Susan Searle
|
98,125
|
100,000
|
-
|
198,125
|
0.03%
|
Hugo Wahnish
|
275,000
|
75,000
|
-
|
350,000
|
0.05%
|
Yngve Myhre
|
400,000
|
200,000
|
-
|
600,000
|
0.09%
|
Kevin Quinn
|
60,929
|
25,000
|
-
|
85,929
|
0.01%
|
Alex Raeber
|
200,000
|
-
|
7,658
|
207,658
|
0.03%
|
Notification and public disclosure of transactions by persons discharging managerial responsibilities.
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
a)
|
Name
|
Peter George (Executive Chairman)
Septima Maguire (Chief Financial Officer)
Susan Searle (Non Executive Director)
Hugo Wahnish (Non Executive Director)
Yngve Myhre (Non Executive Director)
Kevin Quinn (Non Executive Director)
Alex Raeber (Chief Scientific Officer)
|
2
|
Reason for the notification
|
a)
|
Position/status
|
See 1(a) above
|
b)
|
Initial notification /Amendment
|
Initial notification
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
a)
|
Name
|
Benchmark Holdings plc
|
b)
|
LEI
|
2138001UQHM4VZGXUJ19
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares
ISIN: GB00BGHPT808
|
b)
|
Nature of the transaction
|
Subscription for new ordinary shares pursuant to the Placing and/or Open Offer
|
c)
|
Price(s) and volume(s)
|
Director/ PDMR
|
Price(s)
|
Volume(s)
|
Peter George
Septima Maguire
Susan Searle
Hugo Wahnish
Yngve Myhre
Kevin Quinn
Alex Raeber
|
40 pence
40 pence
40 pence
40 pence
40 pence
40 pence
40 pence
|
1,318,219
250,000
100,000
75,000
200,000
25,000
7,658
|
|
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
- Aggregated total
|
Director/ PDMR
|
Aggregated volume
|
Price(s)
|
Aggregated total
|
Peter George
Septima Maguire
Susan Searle
Hugo Wahnish
Yngve Myhre
Kevin Quinn
Alex Raeber
|
1,318,219
250,000
100,000
75,000
200,000
25,000
7,658
|
40 pence
40 pence
40 pence
40 pence
40 pence
40 pence
40 pence
|
£527,287.60
£100,000.00
£40,000.00
£30,000.00
£80,000.00
£10,000.00
£3,063.20
|
|
e)
|
Date of the transaction
|
19 February 2020
|
f)
|
Place of the transaction
|
London Stock Exchange, AIM
|
-Ends-
|
Benchmark Holdings plc
|
Tel: 020 3696 0630
|
|
|
Ivonne Cantu, Investor Relations Director
|
|
Rachel Aninakwah, Communications
|
|
|
|
Numis
|
Tel: 020 7260 1000
|
Freddie Barnfield, Duncan Monteith (NOMAD)
|
|
James Black (Corporate Broking)
|
|
|
|
MHP
|
|
Katie Hunt / Reg Hoare /Alistair de Kare-Silver
|
Tel: 020 3128 8742
[email protected]
|
|
|
About Benchmark
Benchmark's mission is to enable food producers to improve their sustainability and profitability.
We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), sea lice treatments, training and data management tools. Find out more at www.benchmarkplc.com
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHFLFSIFSILFII
|
|